Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy (Q57790286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jeremy A. Squire

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Michael Milosevic

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

Theodorus H Van der Kwast

21 January 2020

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Robert G. Bristow

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

13

Igor Jurisica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Jenna Sykes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

John Thoms

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Maisa Yoshimoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Varune Rohan Ramnarine

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Alice Meng

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Omar Ahmed

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Melania Pintilie

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Adrian S Ishkanian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Chad A Malloff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jennifer A Locke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Wan L Lam

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

26 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

4053-4062

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy: clinical and translational issues

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

NCCN clinical practice guidelines in oncology: prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Predictive models in external beam radiotherapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Integrative analysis of genomic aberrations associated with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

New concepts for phase I trials: evaluating new drugs combined with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

A stepwise framework for the normalization of array CGH data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Integrating copy number polymorphisms into array CGH analysis using a robust HMM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

SeeGH--a software tool for visualization of whole genome array comparative genomic hybridization data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

MD-SeeGH: a platform for integrative analysis of multi-dimensional genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

The p53 protein family and radiation sensitivity: Yes or no?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

7 January 2021

Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

7 January 2021

Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

7 January 2021

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

7 January 2021

Prognostic signatures, cancer metastasis and MYC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26729

7 January 2021

Identifiers

DOI

10.1002/CNCR.26729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281794%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference